Eledon Pharmaceuticals In...

NASDAQ: ELDN · Real-Time Price · USD
2.90
0.07 (2.47%)
At close: May 15, 2025, 3:59 PM
2.89
-0.17%
After-hours: May 15, 2025, 04:05 PM EDT

Eledon Pharmaceuticals Statistics

Share Statistics

Eledon Pharmaceuticals has 59.88M shares outstanding. The number of shares has increased by 55.51% in one year.

Shares Outstanding 59.88M
Shares Change (YoY) 55.51%
Shares Change (QoQ) 0.24%
Owned by Institutions (%) 74.08%
Shares Floating n/a
Failed to Deliver (FTD) Shares 7,337
FTD / Avg. Volume 3.35%

Short Selling Information

The latest short interest is 1.79M, so 2.98% of the outstanding shares have been sold short.

Short Interest 1.79M
Short % of Shares Out 2.98%
Short % of Float 3.33%
Short Ratio (days to cover) 12.2

Valuation Ratios

The PE ratio is -5.66 and the forward PE ratio is -2.71. Eledon Pharmaceuticals's PEG ratio is 0.

PE Ratio -5.66
Forward PE -2.71
PS Ratio 0
Forward PS 3.2
PB Ratio 1.69
P/FCF Ratio -4.23
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Eledon Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.42, with a Debt / Equity ratio of 0.01.

Current Ratio 12.42
Quick Ratio 12.42
Debt / Equity 0.01
Debt / EBITDA -0.03
Debt / FCF -0.02
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-1,139,419.35
Employee Count 31
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -431K
Effective Tax Rate 1.21%

Stock Price Statistics

The stock price has increased by 3.57% in the last 52 weeks. The beta is 0.08, so Eledon Pharmaceuticals's price volatility has been higher than the market average.

Beta 0.08
52-Week Price Change 3.57%
50-Day Moving Average 3.24
200-Day Moving Average 3.57
Relative Strength Index (RSI) 42.14
Average Volume (20 Days) 219,219

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Net Income -35.32M
EBITDA -35.39M
EBIT n/a
Earnings Per Share (EPS) -0.73
Full Income Statement

Balance Sheet

The company has 20.55M in cash and 954K in debt, giving a net cash position of 19.59M.

Cash & Cash Equivalents 20.55M
Total Debt 954K
Net Cash 19.59M
Retained Earnings -355.59M
Total Assets 177.41M
Working Capital 132.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -47.27M and capital expenditures 0, giving a free cash flow of -47.27M.

Operating Cash Flow -47.27M
Capital Expenditures n/a
Free Cash Flow -47.27M
FCF Per Share -0.97
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELDN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ELDN is $16, which is 451.7% higher than the current price. The consensus rating is "Buy".

Price Target $16
Price Target Difference 451.7%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Oct 5, 2020. It was a backward split with a ratio of 1:18.

Last Split Date Oct 5, 2020
Split Type backward
Split Ratio 1:18

Scores

Altman Z-Score -1.3
Piotroski F-Score 1